InsidersTradesSigma
Track the 아미코젠 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 아미코젠 has recorded 4 public disclosures. Market capitalisation: €81.7bn. The latest transaction was filed on 4 May 2026 (Purchase). Among the most active insiders: 아미코젠. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Amicogen es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el mercado XKRX. Se enfoca en el desarrollo de productos biofarmacéuticos y soluciones de salud innovadoras.